COMBINATION THERAPY FOR THE TREATMENT OF PAN-KRAS MUTATED CANCERS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 24, 2024
app pub date -
Aug 8, 2022
filing date -
Aug 8, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
This application relates to methods of treating and/or preventing cancer (e.g., non-small cell lung cancer, small cell lung carcinoma, colorectal cancer, pancreatic cancer, breast cancer, ovarian cancer, biliary cancer and melanoma in subjects in need thereof comprising administering to the patient a therapeutically effective amount of a CDK inhibitor (e.g., milciclib) in combination with a therapeutically effective amount of a DNA damaging agent.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully